Management GEA Restructures Pharma Systems Business
GEA Pharma Systems (GPS) announces group restructure and appointments as it embraces a new corporate philosophy to overcome competitive challenges and develop new markets: The company
Wommelgem/Belgium – To support the expansion of the global GPS network for continuous technologies, a number of important steps have been taken. Comprising five GPS management members, a ConsiGmaTM Steering Committee has been established to manage and co-ordinate the company’s continuous pharmaceutical business units.
As from 1 October 2014, Jan Vugts will assume the role of Director, ConsiGmaTM Technologies and Frans Maas will take on the role of MD of the ‘Centre of Excellence’ in Wommelgem, Belgium. “With the accelerating growth agenda for ConsiGmaTM, it’s time to take our continuous pharmaceutical business — and its built in quality — to the next level,” noted Frans, who will be managing the Centre of Excellence and leading the organisational and business development of the global ConsiGmaTM market. “The investment in this new structure will foster collaboration, accelerate the development of products, processes and solutions and make the business scalable,” added Jan, who will provide high-level technical leadership and drive the current product portfolio.
Growth Potential in Europe and Emerging Economies
Further, in addition to his current role as Business Director, India, Navin Lakhanpaul will succeed Frans Maas and become VP Sales & Marketing for GEA Pharma Systems. Navin will look after the company’s global business (except for North America) and commented: “The growth potential for continuous manufacturing is an exciting opportunity, as are the expansion possibilities in both our key markets in Europe and the pharmerging regions. I look forward to developing the business using a combined application and technology based approach and increasing GEA’s global market share.”